Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Victim port-based design for test area overhead reduction in multiport latch-based memories
Automated processing machine used for processing samples placed on slides and having an output device
Method and system for utilizing Perovskite material for charge storage and as a dielectric
High-performance AHCI interface
Anti-infective agents and uses thereof
Electronic component and a system and method for producing an electronic component
Harmonic sensor
  Randomly Featured Patents
Optical pickup compatible with a digital versatile disk and a recordable compact disk using a holographic ring lens
Ophthalmic electromagnet
Device for exciting synchronous machine
Power drawing circuit for two-wire switching unit
Method and apparatus for determining drill string movement mode
Radiohalogenation of oligonucleotides via trialkylstannylaryl conjugates
Call system and method
Nonwoven fabric made from filaments and artificial leather containing it
Plunger caddy
Image-forming device